Lamothe Jeffrey G.
Insider CIK 1679967 · APVO SVP, CFO and Treasurer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2026-08-06 | 2026-08-10 | 961 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2026-08-06 | 2026-08-10 | 961 | — | $0 | 961 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2026-08-06 | 2026-08-10 | 961 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2026-08-06 | 2026-08-10 | 961 | — | — | 961 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2025-08-06 | 2025-08-08 | 17,300 | — | $0 | 17,300 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2025-07-17 | 2025-07-21 | 5 | — | $0 | 12 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2025-07-17 | 2025-07-21 | 5 | — | $0 | 6 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2025-03-03 | 2025-03-04 | 2 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2025-03-03 | 2025-03-04 | 2 | — | $0 | 36 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2025-03-02 | 2025-03-04 | 3 | — | $0 | 4 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2025-03-02 | 2025-03-04 | 3 | — | $0 | 34 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2024-08-08 | 2024-08-09 | 42 | — | $0 | 41 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2024-08-08 | 2024-08-09 | 272 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2024-08-08 | 2024-08-09 | 42 | — | $0 | 894 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2024-08-08 | 2024-08-09 | 272 | — | $0 | 1,166 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2024-07-17 | 2024-07-19 | 12,825 | — | $0 | 12,825 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2024-03-03 | 2024-03-05 | 3,667 | — | $0 | 3,667 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2024-03-03 | 2024-03-05 | 3,667 | — | $0 | 37,504 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2024-03-02 | 2024-03-05 | 5,500 | — | $0 | 11,000 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2024-03-02 | 2024-03-05 | 5,500 | — | $0 | 33,837 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2024-01-28 | 2024-01-30 | 1,833 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2024-01-28 | 2024-01-30 | 1,833 | — | $0 | 28,337 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2023-08-08 | 2023-08-10 | 1,833 | — | $0 | 3,667 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2023-08-08 | 2023-08-10 | 11,979 | — | $0 | 11,979 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2023-08-08 | 2023-08-10 | 1,833 | — | $0 | 26,504 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2023-08-08 | 2023-08-10 | 11,979 | — | $0 | 24,671 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2023-03-03 | 2023-03-07 | 16,500 | — | $0 | 16,500 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2023-03-03 | 2023-03-07 | 16,500 | — | $0 | 16,500 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2023-03-03 | 2023-03-07 | 3,666 | — | $0 | 7,334 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2023-03-03 | 2023-03-07 | 3,666 | — | $0 | 12,692 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2023-01-29 | 2023-01-30 | 1,834 | — | $0 | 1,833 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2023-01-29 | 2023-01-30 | 1,834 | — | $0 | 9,026 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2022-08-09 | 2022-08-10 | 5,500 | — | $0 | 5,500 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2022-08-09 | 2022-08-10 | 23,958 | — | $0 | 23,958 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2022-08-09 | 2022-08-10 | 5,500 | — | $0 | 5,500 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2022-06-07 | 2022-06-07 | 11,000 | — | $0 | 11,000 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2022-03-04 | 2022-03-04 | 11,000 | — | $0 | 11,000 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2022-01-29 | 2022-02-01 | 1,833 | — | $0 | 3,667 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2022-01-29 | 2022-02-01 | 1,833 | — | $0 | 7,192 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2021-01-29 | 2021-02-17 | 5,500 | — | $0 | 5,500 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2021-01-29 | 2021-02-17 | 16,500 | — | $0 | 16,500 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 1,928 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 2,695 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-07-27 | 2020-07-29 | 2,140 | — | $0 | 2,140 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-07-27 | 2020-07-29 | 7,380 | — | $0 | 7,380 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 4,814 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 4,814 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 2,407 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 2,407 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 3,128 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-02-18 | 2020-03-19 | 134,800 | — | $0 | 134,800 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2019-11-01 | 2019-11-05 | 135,384 | — | $0 | 135,384 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2019-03-01 | 2019-03-04 | 7,318 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2019-03-01 | 2019-03-04 | 7,318 | — | $0 | 77,194 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2019-03-01 | 2019-03-04 | 2,170 | $1.57 | $3.4K | 75,024 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2019-02-28 | 2019-03-04 | 67,400 | — | $0 | 67,400 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2018-03-10 | 2018-03-13 | 6,747 | — | $0 | 7,318 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2018-03-10 | 2018-03-13 | 6,747 | — | $0 | 71,459 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2018-03-10 | 2018-03-13 | 1,583 | $3.13 | $5.0K | 69,876 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2018-03-09 | 2018-03-13 | 67,400 | — | $0 | 67,400 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2018-03-01 | 2018-03-05 | 7,320 | — | $0 | 14,065 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2018-03-01 | 2018-03-05 | 1,717 | $3.04 | $5.2K | 64,712 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2018-03-01 | 2018-03-05 | 7,320 | — | $0 | 66,429 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2018-02-03 | 2018-02-06 | 25,340 | — | $0 | 21,385 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2018-02-03 | 2018-02-06 | 7,514 | $3.24 | $24.3K | 59,109 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2018-02-03 | 2018-02-06 | 25,340 | — | $0 | 66,623 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2017-06-01 | 2017-06-01 | 33,700 | — | $0 | 33,700 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2017-03-10 | 2017-03-13 | 18,863 | — | $0 | 46,725 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2017-03-10 | 2017-03-13 | 6,746 | — | $0 | 65,588 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2017-03-10 | 2017-03-13 | 18,863 | — | $0 | 46,274 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2017-03-10 | 2017-03-13 | 4,990 | $1.78 | $8.9K | 41,284 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2017-03-10 | 2017-03-13 | 1,785 | $1.78 | $3.2K | 27,411 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2017-03-01 | 2017-03-13 | 7,320 | — | $0 | 72,334 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2017-03-01 | 2017-03-13 | 7,320 | — | $0 | 24,386 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2017-03-01 | 2017-03-13 | 1,936 | $2.02 | $3.9K | 22,450 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2017-03-01 | 2017-03-13 | 6,746 | — | $0 | 29,196 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2017-02-24 | 2017-02-27 | 33,700 | — | $0 | 142,232 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2017-02-03 | 2017-02-08 | 25,340 | — | $0 | 79,654 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2017-02-03 | 2017-02-08 | 25,340 | — | $0 | 25,340 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2017-02-03 | 2017-02-08 | 8,274 | $1.92 | $15.9K | 17,066 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2016-08-03 | 2016-08-05 | 50,680 | — | $0 | 50,680 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2016-08-03 | 2016-09-27 | 50,680 | — | $0 | 104,994 | SEC↗ |